Created at Source Raw Value Validated value
Feb. 15, 2023, noon usa

[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "primary vaccination completed with ChAdOx1 nCOV-19", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "primary vaccination completed with ChAdOx1 nCOV-19", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "primary vaccination completed with BNT162b2", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "primary vaccination completed with BNT162b2", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "primary vaccination completed with mRNA-1273", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "primary vaccination completed with mRNA-1273", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "primary vaccination completed with Ad26.COV2.S", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "primary vaccination completed with Ad26.COV2.S", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "primary vaccination completed with ChAdOx1 nCOV-19(AZ)-BNT162b2", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "primary vaccination completed with ChAdOx1 nCOV-19(AZ)-BNT162b2", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "primary and 1st booster vaccination completed with mRNA vaccine", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "primary and 1st booster vaccination completed with mRNA vaccine", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "primary and 1st booster vaccination completed with \u22651 dose of non-mRNA vaccine", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "primary and 1st booster vaccination completed with \u22651 dose of non-mRNA vaccine", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

Jan. 5, 2022, 7 a.m. usa

[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Normal saline", "treatment_type": "Other", "pharmacological_treatment": "TODO"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510) (RBD of SARS-CoV-2 25ug / dose) Adjuvanted with AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "25\u03bcg;1;primary vaccination completed with ChAdOx1 nCOV-19", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "25\u03bcg;1;primary vaccination completed with BNT162b2", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "25\u03bcg;1;primary vaccination completed with mRNA-1273", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "25\u03bcg;1;primary vaccination completed with Ad26.COV2.S", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "25\u03bcg;1;primary vaccination completed with ChAdOx1 nCOV-19-BNT162b2", "treatment_id": 1524, "treatment_name": "As03 adjuvant+gbp510", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "IM", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]